**Core Concept**
Thrombolytic therapy in acute myocardial infarction (AMI) involves the administration of agents that dissolve blood clots to restore coronary blood flow. However, certain conditions increase the risk of bleeding and contraindicate thrombolytic use. The primary concern is the risk of hemorrhagic transformation of an existing cerebral infarction, which can be catastrophic.

**Why the Correct Answer is Right**
A history of cerebrovascular accident (CVA) with hemiparesis within the past month is an absolute contraindication to thrombolytic therapy in the setting of AMI. This is because the patient may have an existing cerebral infarction that is at risk of hemorrhagic transformation. Thrombolytic agents can exacerbate this risk, leading to fatal outcomes. The presence of hemiparesis indicates a significant cerebral infarction, and the risk of bleeding is too high to justify the use of thrombolytics.

**Why Each Wrong Option is Incorrect**
**Option B:** Diabetic retinopathy is not an absolute contraindication to thrombolytic therapy. While patients with diabetes are at increased risk of bleeding, this condition does not pose a significant risk of hemorrhagic transformation of an existing cerebral infarction.

**Option C:** A patient's age more than 70 years is a relative contraindication to thrombolytic therapy. Older patients are at increased risk of bleeding and may have comorbid conditions that increase the risk of complications. However, age alone is not an absolute contraindication.

**Option D:** A patient on warfarin for atrial fibrillation with an INR ratio of 1:8 is at increased risk of bleeding but is not an absolute contraindication to thrombolytic therapy. The INR ratio is a measure of anticoagulation, and a ratio of 1:8 indicates a high level of anticoagulation. However, this does not necessarily preclude the use of thrombolytics.

**Clinical Pearl / High-Yield Fact**
When considering thrombolytic therapy in a patient with a history of CVA, it is essential to evaluate the timing of the previous stroke and the presence of any residual neurological deficits. A patient with a history of CVA within the past month is at high risk of hemorrhagic transformation and should not receive thrombolytic therapy.

**✓ Correct Answer: A. History of CVA with hemiparesis one month ago**